Low-dose methotrexate in myeloproliferative neoplasm models

Haematologica. 2017 Sep;102(9):e336-e339. doi: 10.3324/haematol.2017.165738. Epub 2017 May 26.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Humans
  • Methotrexate / economics
  • Methotrexate / pharmacology
  • Methotrexate / therapeutic use*
  • Mice
  • Myeloproliferative Disorders / drug therapy*
  • Neoplasms / drug therapy
  • Phosphorylation / drug effects
  • STAT3 Transcription Factor / metabolism
  • STAT5 Transcription Factor / metabolism

Substances

  • STAT3 Transcription Factor
  • STAT5 Transcription Factor
  • Methotrexate